Unknown

Dataset Information

0

A New Kid on the Block: Sacituzumab Govitecan for the Treatment of Breast Cancer and Other Solid Tumors.


ABSTRACT: Human trophoblast cell-surface antigen-2 (Trop-2) is a membrane glycoprotein involved in cell proliferation and motility, frequently overexpressed in epithelial tumors. Thus, it represents an attractive target for anticancer therapies. Sacituzumab govitecan (SG) is a third-generation antibody-drug conjugate, consisting of an anti-Trop-2 monoclonal antibody (hRS7), a hydrolyzable linker, and a cytotoxin (SN38), which inhibits topoisomerase 1. Specific pharmacological features, such as the high antibody to payload ratio, the ultra-toxic nature of SN38, and the capacity to kill surrounding tumor cells (the bystander effect), make SG a very promising drug for cancer treatment. Indeed, unprecedented results have been observed with SG in patients with heavily pretreated advanced triple-negative breast cancer and urothelial carcinomas, and the drug has already received approval for these indications. These results are coupled with a manageable toxicity profile, with neutropenia and diarrhea as the most frequent adverse events, mainly of grades 1-2. While several trials are exploring SG activity in different tumor types and settings, potential biomarkers of response are under investigation. Among these, Trop-2 overexpression and the presence of BRCA1/2 mutations seem to be the most promising. We review the available literature concerning SG, with a focus on its toxicity spectrum and possible biomarkers of its response.

SUBMITTER: Pavone G 

PROVIDER: S-EPMC8659286 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7303962 | biostudies-literature
| S-EPMC9263779 | biostudies-literature
| S-EPMC9073796 | biostudies-literature
| S-EPMC8259232 | biostudies-literature
| S-EPMC10113938 | biostudies-literature
| S-EPMC7288263 | biostudies-literature
| S-EPMC4558321 | biostudies-literature
| S-EPMC7597411 | biostudies-literature
| S-EPMC8581633 | biostudies-literature